Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of Upadacitinib Retreatment or Dose Escalation After Loss of Response in Ulcerative Colitis: Data From the Open-Label Extension of the U-ACTIVATE Study.

Gastro hep advances·2026
Same author

The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results From the Phase II GLADIATOR Trial.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Tryptophan pathway metabotypes associate with disease activity and immune-metabolic dysfunction in inflammatory bowel disease.

medRxiv : the preprint server for health sciences·2026
Same author

Mirikizumab is associated with rapid and sustained improvements in novel measures of bowel urgency in moderately-to-severely active ulcerative colitis: 28-week results from the LUCENT-URGE trial.

Journal of Crohn's & colitis·2026
Same author

Epidemiology and Treatment of Inflammatory Bowel Disease in Pregnancy: Results from a Retrospective, Observational Study.

Digestive diseases and sciences·2026
Same author

Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trial.

BMJ open gastroenterology·2026

Related Experiment Video

Updated: Jun 8, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Can serologic markers help determine prognosis and guide therapy?

Marla Dubinsky1

  • 1Pediatric IBD Center, Department of Pediatrics, Cedars-Sinai Medical Center, David Geffen School of Medicine Los Angeles, CA, USA. dubinskym@cshs.org

Digestive Diseases (Basel, Switzerland)
|October 8, 2010
PubMed
Summary

Researchers are seeking biologic markers to predict inflammatory bowel disease (IBD) progression and treatment response. Identifying prognostic indicators aids in crucial management decisions for patients and physicians.

More Related Videos

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

Related Experiment Videos

Last Updated: Jun 8, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

Area of Science:

  • Gastroenterology and immunology research.
  • Focus on inflammatory bowel disease (IBD).

Background:

  • Inflammatory bowel disease (IBD) research is actively seeking predictive biologic markers.
  • Understanding disease progression and treatment response is crucial.

Purpose of the Study:

  • To highlight the importance of identifying biologic markers in IBD.
  • To emphasize the role of prognosis in clinical decision-making.

Main Methods:

  • Literature review and synthesis of current research trends in IBD.
  • Analysis of the impact of prognostic knowledge on patient care.

Main Results:

  • Biologic markers are essential for assessing disease natural history.
  • Prognostic information significantly aids in management decisions.

Conclusions:

  • The development of predictive biologic markers is a key research priority in IBD.
  • Accurate prognosis improves patient-physician communication and treatment planning.